(Q38432682)

3 September 2017

title

Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: Comparison of treatment outcomes (English)

1 reference

3 September 2017

1 reference

Tae Hyun Kim

6

0 references

author name string

Yeon-Joo Kim

1

1 reference

3 September 2017

Kwan Ho Cho

2

1 reference

3 September 2017

Hong Ryull Pyo

3

1 reference

3 September 2017

Kang Hyun Lee

4

1 reference

3 September 2017

Sung Ho Moon

5

1 reference

3 September 2017

Kyung Hwan Shin

7

1 reference

3 September 2017

Joo-Young Kim

8

1 reference

3 September 2017

Young-kyung Kim

9

1 reference

3 September 2017

Se Byeong Lee

10

1 reference

3 September 2017

publication date

23 October 2014

1 reference

Strahlentherapie und Onkologie

3 September 2017

published in

1 reference

3 September 2017

volume

191

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

321-329

1 reference

Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Physician visits prior to treatment for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

The change of prostate cancer treatment in Korea: 5 year analysis of a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

A phase II study of hypofractionated proton therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Propensity scores: help or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Long term rectal function after high-dose prostatecancer radiotherapy: results from a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-014-0765-3

Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer

21 January 2018

1 reference

12 December 2020

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

1 reference

12 December 2020

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

12 December 2020

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

1 reference

12 December 2020

Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: phase I/II randomized placebo-controlled trial

1 reference

12 December 2020

High-dose (80 Gy) intensity-modulated radiation therapy with daily image-guidance as primary treatment for localized prostate cancer

1 reference

12 December 2020

10.1007/S00066-014-0765-3

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1011714538

0 references

1 reference